The use of aromatase inhibitors for ovulation induction and superovulation

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 5, 2013, Pages 1838-1844

  Pavone, Mary Ellen ^a,b   Bulun, Serdar E ^a,b  

^a Division of Reproductive Biology Research   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; ANASTROZOLE; AROMATASE INHIBITOR; CLOMIFENE CITRATE; ESTRADIOL; EXEMESTANE; FADROZOLE; FOLLITROPIN; FORMESTANE; LETROZOLE; METFORMIN; PLACEBO; PROGESTERONE; TRIAZOLE DERIVATIVE;

ARTHRALGIA; ARTICLE; COMPARATIVE EFFECTIVENESS; CONGENITAL HEART DISEASE; DIATHERMY; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG SAFETY; ENDOMETRIAL THICKNESS; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE INFERTILITY; FOLLICULAR PHASE; HUMAN; LAPAROSCOPIC OVARIAN DIATHERMY; LETHARGY; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SUPEROVULATION; UNEXPLAINED INFERTILITY; ALGORITHM; ANOVULATION; DECISION TREE; DRUG EFFECT; EVIDENCE BASED MEDICINE; FEMALE; PATHOPHYSIOLOGY; REVIEW;

ALGORITHMS; ANOVULATION; AROMATASE INHIBITORS; DECISION TREES; ENDOMETRIOSIS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; SUPEROVULATION;

MLCS; MLOWN;

EID: 84877695108     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1328     Document Type: Article

References (44)

1. Guzick D. Polycystic ovary syndrome: symptomatology, pathophysiology, and epidemiology. Am J Obstet Gynecol. 1998;179:S89-S93.
2. Franks S, Adams J, Mason H, Polson D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol. 1985;12:605-632.
3. Kistner RW. Induction of ovulation with clomiphene citrate (clomid). Obstet Gynecol Surv. 1965;20:873-900.
4. Badawy A, Mosbah A, Shady M. Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril. 2008;89:1209-1212.
5. Badawy A, State O, Abdelgawad S. N-Acetyl cysteine and clomiphene citrate for induction of ovulation in polycystic ovary syndrome: a cross-over trial. Acta Obstet Gynecol Scand. 2007;86: 218-222.
6. Badawy A, Baker El Nashar A, El Totongy M. Clomiphene citrate plus N-acetyl cysteine versus clomiphene citrate for augmenting ovulation in the management of unexplained infertility: a randomized double-blind controlled trial. Fertil Steril. 2006;86:647-650.
7. Mitwally MF, Casper RF. Potential of aromatase inhibitors for ovulation and superovulation induction in infertile women. Drugs. 2006;66:2149-2160.
8. Lee VC, Ledger W. Aromatase inhibitors for ovulation induction and ovarian stimulation. Clin Endocrinol (Oxf). 2011;74:537-546.
9. Reddy J, Oktay K. Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer. Fertil Steril. 2012;98:1363-1369.
10. Garcia-Velasco JA. The use of aromatase inhibitors in in vitro fertilization. Fertil Steril. 2012;98:1356-1358.
11. Attar E, Bulun SE. Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update. 2006;12: 49-56.
12. Simpson ER, Mahendroo MS, Nichols JE, Bulun SE. Aromatase gene expression in adipose tissue: relationship to breast cancer. Int J Fertil Menopausal Stud. 1994;39(suppl 2):75-83.
13. Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973; 36:207-214.
14. Bulun SE, Mahendroo MS, Simpson ER. Aromatase gene expression in adipose tissue: relationship to breast cancer. J Steroid Biochem Mol Biol. 1994;49:319-326.
15. Bulun SE. Endometriosis. N Engl J Med. 2009;360:268-279.
16. Pavone ME, Bulun SE. Aromatase inhibitors for the treatment of endometriosis. Fertil Steril. 2012;98:1370-1379.
17. Polyzos NP, Fatemi HM, Zavos A, et al. Aromatase inhibitors in post-menopausal endometriosis. Reprod Biol Endocrinol. 2011;9: 90.
18. Bajetta E, Zilembo N, Bichisao E, et al. Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors. Ann Oncol. 2000;11:1017-1022.
19. Geisler J, King N, Anker G, et al. In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients. Clin Cancer Res. 1998;4:2089-2093.
20. Geisler J, King N, Dowsett M, et al. Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer. Br J Cancer. 1996;74:1286-1291.
21. Plourde PV, Dyroff M, Dowsett M, Demers L, Yates R, Webster A. ARIMIDEX: a new oral, once-a-day aromatase inhibitor. J Steroid Biochem Mol Biol. 1995;53:175-179.
22. Santen RJ, Manni A, Harvey H, Redmond C. Endocrine treatment of breast cancer in women. Endocr Rev. 1990;11:221-265.
23. Dowsett M, Jones A, Johnston SR, Jacobs S, Trunet P, Smith IE. In vivo measurement of aromatase inhibition by letrozole(CGS20267) in postmenopausal patients with breast cancer. Clin Cancer Res. 1995;1:1511-1515.
24. Ferrero S, Venturini PL, Ragni N, Camerini G, Remorgida V. Pharmacological treatment of endometriosis: experience with aromatase inhibitors. Drugs. 2009;69:943-952.
25. Casper RF, Mitwally MF. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clin Obstet Gynecol. 2011;54:685-695.
26. Casper RF, Mitwally MF. A historical perspective of aromatase inhibitors for ovulation induction. Fertil Steril. 2012;98:1352-1355.
27. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75:305-309.
28. Bayar U, Tanriverdi HA, Barut A, Ayoglu F, Ozcan O, Kaya E. Letrozole vs. clomiphene citrate in patients with ovulatory infertility. Fertil Steril. 2006;85:1045-1048.
29. Atay V, Cam C, Muhcu M, Cam M, Karateke A. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Int Med Res. 2006;34:73-76.
30. Kamath MS, Aleyamma TK, Chandy A, George K. Aromatase inhibitors inwomenwith clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial. Fertil Steril. 2010;94:2857-2859.
31. Abu Hashim H, Shokeir T, Badawy A. Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril. 2010;94:1405-1409.
32. Abu Hashim H, Mashaly AM, Badawy A. Letrozole versus laparoscopic ovarian diathermy for ovulation induction in clomipheneresistant women with polycystic ovary syndrome: a randomized controlled trial. Arch Gynecol Obstet. 2010;282:567-571.
33. Begum MR, Ferdous J, Begum A, Quadir E. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertil Steril. 2009;92:853-857.
34. Polyzos NP, Tsappi M, Mauri D, Atay V, Cortinovis I, Casazza G. Aromatase inhibitors for infertility in polycystic ovary syndrome. The beginning or the end of a new era? Fertil Steril. 2008;89:278-280.
35. Badawy A, Shokeir T, Allam AF, Abdelhady H. Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstet Gynecol Scand. 2009; 88:187-191.
36. Badawy A, Elnashar A, Totongy M. Clomiphene citrate or aromatase inhibitors for superovulation in women with unexplained infertility undergoing intrauterine insemination: a prospective randomized trial. Fertil Steril. 2009;92:1355-1359.
37. Samani FG, Farzadi L, Nezami N, Tarzamni MK, Soleimani F. Endometrial and follicular development following letrozole intervention in unexplained infertile patients failed to get pregnant with clomiphene citrate. Arch Gynecol Obstet. 2009;280:201-205.
38. Fouda UM, Sayed AM. Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trial. Reprod Biol Endocrinol. 2011;9:84.
39. Abu Hashim H, El Rakhawy M, Abd Elaal I. Randomized comparison of superovulation with letrozole vs. clomiphene citrate in an IUI program for women with recently surgically treated minimal to mild endometriosis. Acta Obstet Gynecol Scand. 2012;91:338-345.
40. Biljan M, Hemming R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole with gonadotropins. Fertil Steril. 2005;84(suppl 1):S95.
41. Tulandi T, Martin J, Al-Fadhli R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril. 2006;85:1761-1765.
42. Casper RF, Mitwally MF. Review: aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab. 2006;91:760-771.
43. Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol. 2005;192:381-386.
44. Dicken CL, Nakhuda GS, Guarnaccia MM, Sauer MV, Lobo RA. Triplet pregnancy after ovulation induction with an aromatase inhibitor. Fertil Steril. 2008;90:1199.e9-e11.